Who
Gerard J. Michel
Director
Company insider
Files Form 4 as: Director, Beta Bionics; Chief Executive Officer, Delcath Systems; CFO and VP, Corp. Development, Vericel; CFO, VP of Corp and Dev/Treas, Biodel; CFO & VP, Corp. Development, Nps Pharmaceuticals; Director, Ep Medsystems.
In numbers
- Trades disclosed
- 161
- Buys
- 14
- Sells
- 13
- Bought
- $1.6M
- Sold
- $2.9M
- Companies
- 6
- Companies where not an officer
- 2
- First trade
- 17 Jan 2006
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —16,965 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —16,965 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Bought | $100K11,200 at $8.96 | filing |
| 2 Mar 2026filed 3 Mar 2026 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Bought | $100K11,200 at $8.96 | filing |
| 17 Feb 2026filed 18 Feb 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —97,500 at $0.00 | filing |
| 13 Jan 2026filed 14 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —3,997 at $0.00 | filing |
| 13 Jan 2026filed 14 Jan 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —3,997 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Bought | $98K11,500 at $8.53 | filing |
| 26 Mar 2025filed 27 Mar 2025 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —12,547 at $0.00 | filing |
| 7 Feb 2025filed 7 Feb 2025 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —390,000 at $0.00 | filing |
| 22 Oct 2024filed 23 Oct 2024 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code M | $2,16716,666 at $0.13 | filing |
| 22 Oct 2024filed 23 Oct 2024 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Code M | $100K16,666 at $6.00 | filing |
| 19 Mar 2024filed 19 Mar 2024 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Code A | $150K40,323 at $3.72 | filing |
| 12 Feb 2024filed 14 Feb 2024 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —301,500 at $0.00 | filing |
| 8 Dec 2023filed 11 Dec 2023 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Bought | $100K34,000 at $2.94 | filing |
| 18 Aug 2023filed 21 Aug 2023 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code X | $4,04431,110 at $0.13 | filing |
| 18 Aug 2023filed 21 Aug 2023 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Code X | $140K31,110 at $4.50 | filing |
News
Delcath Systems, Inc.: Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal MelanomaDCTH · finanznachrichten.de · 19 Oct 2026Head-To-Head Analysis: Delcath Systems (NASDAQ:DCTH) & Neogen (NASDAQ:NEOG)DCTH · themarketsdaily.com · 18 Oct 2026Analyzing Green Thumb Industries (OTCMKTS:GTBIF) and Delcath Systems (NASDAQ:DCTH)DCTH · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Gerard J. Michel; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.